Defecetive Drugs: adrugrecall.com
CELEBREX
Sign up for our newsletter
to receive breaking news about drugs to watch
Contact A Lawyer
Near You
Contact us today for a complimentary consultation with a qualified attorney near you.
Osteoarthritis
Celebrex entered the U.S. market in 1999 intending to help relieve symptoms of osteoarthritis. An immediate hit, Celebrex osteoarthritis drug had millions of prescriptions written, making $2.2 billion in the first year. Commonly affecting fingers, knees, hips, back, and feet, osteoarthritis is a degenerative arthritis. Eventually, osteoarthritis will break down the cartilage and bone, which can cause pain and stiffness for osteoarthritis patients.
Osteoarthritis patients already were suffering the painful effects of the joint disease when the aggressive marketing strategies of Celebrex depicted a more enjoyable lifestyle if using the drug. The controversial strategies used for the osteoarthritis drug caused the FDA to send Celebrex maker a letter due to the inaccurate representations of the drug. The company also tried to have certain Celebrex warning labels removed in order to further increase desirability and sales of the osteoarthritis drug.
If you have taken Celebrex arthritis drug and have suffered adverse reactions because of it, please contact us to speak with a Celebrex lawyer for more information on rheumatoid arthritis.
More Celebrex Resources
MedLine Plus Drug Information - Guide to prescription and over-the-counter medications provided by the United States Pharmacopeia.
Celebrex - A source of information about relief from arthritis pain including Osteoarthritis and Rheumatoid Arthritis.
CELEBREX IN THE NEWS
- April 23, 2007 - Five Plaintiffs File Celebrex Lawsuit Seeking Damages
- April 2, 2007 - TV Ads For Celebrex to Resume After Side Effects Scare
- March 5, 2007 - Celebrex Should Be Last Resort, Heart Experts Say
- March 2, 2006 - New Study Reveals Celebrex Increases Heart Attack Risks
- February 28, 2006 - First Celebrex lawsuit in the Country Going to Trial
- December 7, 2005 - Celebrex lawsuit filed in federal court
- December 2, 2005 - Celebrex, Vioxx not Safe on Stomach
- November 16, 2005 - Another Vioxx and Celebrex Danger
- August 2, 2005 - FDA orders Celebrex black box warnings
- August 1, 2005 - Pfizer to add Celebrex warnings to labeling
- June 16, 2005 - FDA sends Pfizer Celebrex label change proposals
- April 15, 2005 - Study finds Celebrex as dangerous as Vioxx
- March 29, 2005 - What can be learned from the Celebrex controversy?
- March 23, 2005 - American Heart Association making Celebrex recommendations
- March 9, 2005 - Celebrex, other COX-2 drugs being cast off
- February 24, 2005 - Louisiana's Medicaid program to curb Celebrex, Bextra prescriptions
- February 23, 2005 - New Celebrex trial will be conducted
- February 18, 2005 - FDA panel rules Celebrex increases heart risks
- February 18, 2005 - FDA panel concludes Celebrex can remain on the market
- January 31, 2005 - Public Citizen accuses Pfizer of hiding Celebrex study
- January 24, 2005 - Group calls on the FDA to ban Celebrex, Bextra
- January 13, 2005 - Celebrex ads misleading, says the government
- January 4, 2005 - Class action lawsuit filed against Pfizer Inc. over Celebrex
- December 31, 2004 - Celebrex prescriptions fallen by nearly half
- December 27, 2004 - Public Citizen calls for drug ban
- December 24, 2004 - FDA issues advisory to doctors about Celebrex and Bextra
- December 21, 2004 - Even without a ban, Celebrex sales expected to plunge
- December 20, 2004 - Pfizer continues to defends its controversial drug Celebrex
